CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,765,795
- in 18 filings, $4.9M under 10b5-1 plans
Net −$5,765,795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-07 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −15 | $20.74 | $311 | 4,773 |
| 2025-03-07 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −15 | $20.74 | $311 | 4,770 |
| 2025-03-07 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −15 | $20.74 | $311 | 4,770 |
| 2025-03-07 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −15 | $20.74 | $311 | 4,770 |
| 2025-03-04 | Oelschlager Kristen M Chief Operating Officer | Option exercise | +13,811 | 167,604 | ||
| 2025-03-04 | Oelschlager Kristen M Chief Operating Officer | Shares withheld for taxes | −3,640 | $22.23 | $81K | 163,964 |
| 2025-03-04 | Oelschlager Kristen M Chief Operating Officer | Grant or award · Restricted Stock Units | +47,838 | 47,838 | ||
| 2025-03-04 | Oelschlager Kristen M Chief Operating Officer | Option exercise · Restricted Stock Units | −13,811 | 41,432 | ||
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise 10b5-1 | +31,109 | 111,927 | ||
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Shares withheld for taxes 10b5-1 | −7,576 | $22.23 | $168K | 104,351 |
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,247 | $20.86 | $26K | 103,104 |
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,022 | $20.86 | $42K | 69,059 |
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,739 | $20.86 | $36K | 58,834 |
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −172 | $20.86 | $4K | 4,938 |
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −169 | $20.86 | $4K | 4,935 |
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −169 | $20.86 | $4K | 4,935 |
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −169 | $20.86 | $4K | 4,935 |
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Grant or award · Restricted Stock Units 10b5-1 | +111,948 | 111,948 | ||
| 2025-03-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise · Restricted Stock Units 10b5-1 | −31,109 | 93,328 | ||
| 2025-03-04 | Juvenal Tobin W Chief Commercial Officer | Option exercise | +13,811 | 83,754 |
Page 24 of 45 · 897 trades